Medfusion Parts Ways with Allscripts in Payment Dispute
Due to unresolved payment disputes between the two companies, patient portal vendor Medfusion announced that it has ended its business relationship with health IT vendor Allscripts. Medfusion, a partner since 2009, was providing the portal to approximately 30,000 Allscripts providers.
The Allscripts providers who use Medfusions portal technology will not experience any immediate lapse in service, according to the announcement, and they will be given an opportunity to secure direct service from Medfusion. Users of the portal technology electing to continue service with Medfusion will have access to their portal while their service is transferred during this critical time leading up to Meaningful Use enablement." Some practices are in Stage 2 of the electronic health records meaningful use program, in which a patient portal is necessary to comply with patient engagement criteria.
Allscripts does not as a matter of policy, speak publicly to specific terms of contractual relationships with its vendors, the Chicago-based company said in response to a query. Today, several hundred Allscripts physician practice clients, mostly small and medium size groups, are live on the competitors portal. Any other figures cannot be validated by Allscripts. Our absolute focus is on our clients and providing them with the best possible consumer/patient engagement solutions.
In March 2013, Allscripts acquired health information exchange vendor dbMotion, whose product line included a patient portal. Nevertheless, Allscripts provides a patient portal called FollowMyHealth, which was also acquired at the same time as the dbMotion acquisition, from cloud-based patient and consumer engagement vendor Jardogs. It has been commercially available since before it was purchased by Allscripts.
The end of a long-standing contract is never easy, said Vern Davenport, Medfusion president, in a written statement. "However, for us at Medfusion, we believe that this is best for the healthcare providers and patients we serve. Provider groups with questions can contact the company for more information here.